Ted Ross | Director Global Vaccine Development
Cleveland Clinic

Ted Ross, PhD, is the Global Director of Vaccine Development at Cleveland Clinic. He develops universal vaccines to target multiple strains, variants and types of viruses with the goal for these vaccines is to increase the protection, while decreasing the amount of booster shots required to maintain this protection. His laboratory has developed a novel technology called Computationally Optimized Broadly Reactive Antigen (COBRA) to create long-lasting universal vaccines that protect against the seasonal influenza viruses, animal-borne influenza (including swine and avian flu) and other viruses, including COVID, RSV, and dengue. Dr. Ross has published more than 230 peer-reviewed papers and book chapters on infectious disease and vaccine development. He participates in several vaccine working groups, including at the NIH, the U.S. Centers for Disease Control and Prevention and the World Health Organization. He is an editorial board member of Vaccine. He is the President-Emeritus of the International Society for Vaccines. Dr. Ross completed his undergraduate and graduate studies in zoology and microbiology at the University of Arkansas. He received his doctorate from Vanderbilt University and was awarded the inaugural Sidney P. Colowick Award in Outstanding Graduate Research. Dr. Ross performed post-doctoral fellowships at Duke University and at Emory University.